The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Cliona O’Dowd

The fundie betting big on China – with help from AI

November 5, 2024
Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.
Read Transcript

Chinese equities have staged a volatile comeback on Beijing’s latest promise of stimulus measures, but JO Hambro’s Samir Mehta isn’t one to follow the crowd.
 
With one eye on Beijing’s ­efforts to revive the Chinese economy, Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders – and he’s using AI to do the early legwork.
 
“Particularly in the last five years, well-managed businesses in China have understood that for the first time in 40 years, neither the Chinese government nor the PBOC are going to come to their rescue in terms of big stimulus packages,” Mr Mehta said.
 
“We don’t know how big the latest stimulus package will be. But we do know that the better managed companies in China are cutting costs, reducing working capital, reducing capital expenditure, and assuming that growth is going to be quite challenged. And if they have excess cash, they’re buying back shares or returning money to shareholders.”
 
Along with cutting costs and spending, Chinese companies, in particular, have been preparing for a Donald Trump presidency, determined not to get burned like the last time. “Any company you speak to across Asia today is thinking about Plan B, about a contingency plan,” Mr Mehta said.
 
“Take the shoe manufacturing companies for the likes of Nike and Adidas. They used to have 90 per cent of their shoes manufactured in China. Today it’s less than 20 per cent in China. They’re in Indonesia and Vietnam.”
 
Technology giant Tencent is one of the biggest holdings in the Pendal Asian Share Fund, which Mr Mehta co-manages. The fund invests in Asia ex-Japan, with a focus on China, Taiwan, India and ASEAN countries. Tencent has bought back about $US8bn ($12.1bn) of shares so far this year, with estimates its capital return to shareholders could reach $US13bn by the end of the year, ­including dividends.
 
Alongside the tech giant, the fund’s biggest holdings include names such as chipmaker TSMC, Indian motorcycle maker Bajaj Auto and Tata Consultancy ­Services.
 
But one of the top performers in its portfolio, with a one-year share price surge of 150 per cent, is Jentech Precision, a Taiwan-based tech company that makes “heat spreaders” to dissipate heat to help cool AI servers.
 
Jentech is one of those companies that fits into the chain of manufacturing but is not well talked about. The decision to invest was only made possible with the use of ChatGPT.
 
“We had no clue about the company. We had no information,” Mr Mehta said. “Usually you have sell side coverage, so that would give us some information on the company, what the background was, but with Jentech there was no sell side coverage.
 
“We downloaded their annual reports, got hold of their presentations and fed them through the models, and then tried to understand who the competitors are. It was the first time we had used ChatGPT for analysis.”
 
The fund now uses ChatGPT as a core part of its analysis for stock picking. 

Mr Mehta will present at the Sohn Australia conference in Adelaide next month. While keeping quiet on his chosen stock, he said his top pick was a Chinese company with a peer listed in the US.
 
“I want to focus people’s attention on thinking around this country, that many say is uninvestible,” he said. “It fits into the category of having great management, doing all the right things, including buybacks of shares.
 
“They have a peer that is listed in the US and well admired … and it fits into my narrative of what I would call redemption.”
 
This year’s Sohn Hearts & Minds will be held on Friday, November 15 at Festival Theatre in Adelaide. The annual conference, which has been running since 2016, raises funds for medical research. It is on track to top $70m in total funds raised over the past eight years by November.
 
Themes for this year’s event will explore space, AI, geopolitics, biosciences and investing.
 
A host of top stock pickers outline their best pick for the coming year, including leading investment experts Jordan Katz, managing director at Advent Global Opportunities in Boston; Beeneet ­Kothari, chief executive at New York-based Tekne Capital Management; Ricky Sandler, CEO of Eminence Capital; and Sydney-based ­Vihari Ross, portfolio manager at Antipodes Partners.
 
It is being held in partnership with the South Australian government.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 5 November 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Chinese equities have staged a volatile comeback on Beijing’s latest promise of stimulus measures, but JO Hambro’s Samir Mehta isn’t one to follow the crowd.
 
With one eye on Beijing’s ­efforts to revive the Chinese economy, Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders – and he’s using AI to do the early legwork.
 
“Particularly in the last five years, well-managed businesses in China have understood that for the first time in 40 years, neither the Chinese government nor the PBOC are going to come to their rescue in terms of big stimulus packages,” Mr Mehta said.
 
“We don’t know how big the latest stimulus package will be. But we do know that the better managed companies in China are cutting costs, reducing working capital, reducing capital expenditure, and assuming that growth is going to be quite challenged. And if they have excess cash, they’re buying back shares or returning money to shareholders.”
 
Along with cutting costs and spending, Chinese companies, in particular, have been preparing for a Donald Trump presidency, determined not to get burned like the last time. “Any company you speak to across Asia today is thinking about Plan B, about a contingency plan,” Mr Mehta said.
 
“Take the shoe manufacturing companies for the likes of Nike and Adidas. They used to have 90 per cent of their shoes manufactured in China. Today it’s less than 20 per cent in China. They’re in Indonesia and Vietnam.”
 
Technology giant Tencent is one of the biggest holdings in the Pendal Asian Share Fund, which Mr Mehta co-manages. The fund invests in Asia ex-Japan, with a focus on China, Taiwan, India and ASEAN countries. Tencent has bought back about $US8bn ($12.1bn) of shares so far this year, with estimates its capital return to shareholders could reach $US13bn by the end of the year, ­including dividends.
 
Alongside the tech giant, the fund’s biggest holdings include names such as chipmaker TSMC, Indian motorcycle maker Bajaj Auto and Tata Consultancy ­Services.
 
But one of the top performers in its portfolio, with a one-year share price surge of 150 per cent, is Jentech Precision, a Taiwan-based tech company that makes “heat spreaders” to dissipate heat to help cool AI servers.
 
Jentech is one of those companies that fits into the chain of manufacturing but is not well talked about. The decision to invest was only made possible with the use of ChatGPT.
 
“We had no clue about the company. We had no information,” Mr Mehta said. “Usually you have sell side coverage, so that would give us some information on the company, what the background was, but with Jentech there was no sell side coverage.
 
“We downloaded their annual reports, got hold of their presentations and fed them through the models, and then tried to understand who the competitors are. It was the first time we had used ChatGPT for analysis.”
 
The fund now uses ChatGPT as a core part of its analysis for stock picking. 

Mr Mehta will present at the Sohn Australia conference in Adelaide next month. While keeping quiet on his chosen stock, he said his top pick was a Chinese company with a peer listed in the US.
 
“I want to focus people’s attention on thinking around this country, that many say is uninvestible,” he said. “It fits into the category of having great management, doing all the right things, including buybacks of shares.
 
“They have a peer that is listed in the US and well admired … and it fits into my narrative of what I would call redemption.”
 
This year’s Sohn Hearts & Minds will be held on Friday, November 15 at Festival Theatre in Adelaide. The annual conference, which has been running since 2016, raises funds for medical research. It is on track to top $70m in total funds raised over the past eight years by November.
 
Themes for this year’s event will explore space, AI, geopolitics, biosciences and investing.
 
A host of top stock pickers outline their best pick for the coming year, including leading investment experts Jordan Katz, managing director at Advent Global Opportunities in Boston; Beeneet ­Kothari, chief executive at New York-based Tekne Capital Management; Ricky Sandler, CEO of Eminence Capital; and Sydney-based ­Vihari Ross, portfolio manager at Antipodes Partners.
 
It is being held in partnership with the South Australian government.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 5 November 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Australian, published on Nov 05, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 3, 2025

How to beat the market without owning Nvidia shares

Vihari Ross' global fund returned more than 20 per cent in the year to September 30 versus about 10 per cent for the benchmark without owning Nvidia, Meta, Tesla, Apple or Broadcom.

Read More
November 12, 2025

Square Peg's Ben Hensman names top picks in a hot tech sector

“We’re really looking for people who have that strong growth arc. Even though they’ve reached material scale, they’re still changing and moulding their company to move really fast, and they’re curious.”

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

'Here to pitch the parent company': Jim Chalmers' Sohn pick

The federal treasurer got into the spirit of the Sohn Hearts & Minds event with a big-picture investment tip – and a dig at our nation’s fundies.

Read More
November 14, 2025

Forget Trump volatility says top investor and focus on China threat to Australia

Australian investors should be more worried about China than sweating on Federal Reserve independence and other market obsessions to do with Donald Trump, says billionaire conservative Baron Michael Hintze.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Activism without proxy fights is like ‘Catholicism without hell’: Loeb

An older, wiser Dan Loeb reckons his activist approach has changed, but the Wall Street icon will never put away the big stick.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Net zero move good, but Libs need ‘north star’: Lord Hintze

Michael Hintze, one of Australia’s richest international ­billionaires and donor to ­conservative parties, says the Liberals are lacking a “north star” but dumping net zero was a smart move.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Third Point’s Loeb leads bullish investors despite stock slump

Major investors say the global economy is strong enough to withstand a bubble in artificial intelligence and turmoil in private credit markets despite a sharp fall on Wall Street and the ASX over the past week.

Read More
November 14, 2025

The 9 hottest stock tips from this year’s Sohn fund managers

Defying markets gloom, top investment chiefs pitched their best global ideas, from an “OG in AI” to a retirement giant.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

10 top stock picks from Sohn Hearts & Minds conference 2025

Global fund managers gathered at the 2025 Sohn Hearts & Minds conference to pitch their best stock ideas. Here are all 10 tips in the order they were presented.

Read More
Photo: Kajie FordPhoto: Kajie FordPhoto: Kajie FordPhoto: Kajie Ford
November 18, 2025

Anthony Scaramucci says everyone in Trump's orbit hates him

“The Mooch”, as he’s affectionately known, is a man in high demand. He’s flown into Sydney to headline the Sohn Hearts & Minds conference at the Opera House, an investment community jamboree that raises money for charity. He landed in London the night before, and will leave Sydney the next day for the brutal 24-hour return to New York.

Read More
November 14, 2025

Queenstown to host 2026 Sohn Hearts & Minds Conference

We're thrilled to announce Queenstown, New Zealand, as the destination for the 2026 Investment Leaders Conference, to be held on Friday 6 November.

Read More
November 23, 2025

Nvidia's wild swings and 11 Sohn Hearts & Minds stock picks reviewed

Equity Mates reviewed the high conviction stock picks presented at the 2025 Sohn Hearts & Minds Conference.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.